Although the rate of childhood vaccination refusal by parents is low overall, about 10% refuse or delay at least 1 vaccine and many express concerns. Providers must be ready to address these concerns. Medscape Medical News
No Comments »
Filed under: General Health News
Children and adolescents who use cell phones are not at a statistically significant increased risk for brain cancer, according to a new international study. Medscape Medical News
No Comments »
Filed under: General Health News
As the percentage of older people rises, strategies shift focus to bring needed care for diabetes and other chronic conditions into communities, particularly for African-American patients. Medscape Medical News
No Comments »
Filed under: General Health News
(MedPage Today) — McNeil Consumer Healthcare has announced it is lowering the maximum daily dose instructions for Extra Strength Tylenol to six pills a day (3,000 mg) to reduce the risk of acetaminophen overdose.
No Comments »
Filed under: General Health News
(MedPage Today) — Healthcare spending in the U.S. is expected to grow 5.8% per year from 2010 to 2020, outpacing growth in the gross domestic product by 1.1 percentage points, according to a report from the Centers for Medicare and Medicaid Services.
No Comments »
Filed under: General Health News
(MedPage Today) — McNeil Consumer Healthcare has announced it is lowering the maximum daily dose instructions for Extra Strength Tylenol to six pills a day (3,000 mg) to reduce the risk of acetaminophen overdose.
No Comments »
Filed under: Pharmacy News
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today reported its financial results for the second quarter ended June 30, 2011.
No Comments »
Filed under: Pharmacy News
Ipsen today announced that its partner Inspiration Biopharmaceuticals, Inc. presented data from its clinical development program for OBI-1, an intravenous (IV) recombinant porcine factor VIII product (rpFVIII), intended for the treatment of bleeding in people with hemophilia A with inhibitors and in people with acquired hemophilia.
No Comments »
Filed under: Pharmacy News
Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the “Company”) announced the completion of patient recruitment for the ongoing Phase 3 trial with perifosine in refractory advanced colorectal cancer. The trial, involving over 430 patients, is being conducted pursuant to a Special Protocol Assessment (SPA) with the Food and Drug Administration (FDA) and with Fast Track [...]
No Comments »
Filed under: Pharmacy News
Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) announced completion of patient enrollment in its Phase 3 registration trial of KRX-0401 (perifosine) for the treatment of refractory, advanced colorectal cancer…
No Comments »
Filed under: Pharmacy News
